Search research articles
Contact Us
Filters
Showing results (61-70 of 332) with videos related to
Page
of 34
Sort By:
Journal of Molecular Neuroscience : MN
|
June 8, 2006
Characterization of the human beta-secretase 2 (BACE2) 5'-flanking region: identification of a 268-bp region as the basal BACE2 promoter
Bryan Maloney, Yuan-Wen Ge, Nigel H Greig, et al.
CNS & Neurological Disorders Drug Targets
|
October 28, 2014
Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus
Gohar Mushtaq, Nigel H Greig, Jalaluddin A Khan, et al.
Neuroscience and Biobehavioral Reviews
|
March 15, 2023
Current update on management strategies for neurological and psychological disorders
Rupesh K Gautam, Aziz Unnisa, Nigel H Greig, et al.
Pharmacological Research
|
November 13, 2022
Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment
Katherine O Kopp, Elliot J Glotfelty, Yazhou Li, et al.
Neuroscience Letters
|
December 2, 2009
Memantine treatment decreases levels of secreted Alzheimer's amyloid precursor protein (APP) and amyloid beta (A beta) peptide in the human neuroblastoma cells
Balmiki Ray, Pradeep K Banerjee, Nigel H Greig, et al.
International Journal of Alzheimer'S Disease
|
September 28, 2010
Neuroinflammation, AD, and Dementia
Marcella Reale, Talma Brenner, Nigel H Greig, et al.
Annals of Neurology
|
August 23, 2014
Amyloid-β precursor protein synthesis inhibitors for Alzheimer's disease treatment
Nigel H Greig, Kumar Sambamurti, Debomoy K Lahiri, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
February 18, 2014
Lessons from a BACE1 inhibitor trial: off-site but not off base
Debomoy K Lahiri, Bryan Maloney, Justin M Long, et al.
Frontiers in Cell and Developmental Biology
|
December 24, 2019
Neuroinflammation as a Factor of Neurodegenerative Disease: Thalidomide Analogs as Treatments
Yoo Jin Jung, David Tweedie, Michael T Scerba, et al.
Neurobiology of Aging
|
December 11, 2007
Presenilin-1 mutation impairs cholinergic modulation of synaptic plasticity and suppresses NMDA currents in hippocampus slices
Yue Wang, Nigel H Greig, Qian-sheng Yu, et al.
Page
of 34
Search research articles
Search
Showing results (61-70 of 332) with videos related to
Sort By:
Page
of 34
Journal of Molecular Neuroscience : MN
|
June 8, 2006
Characterization of the human beta-secretase 2 (BACE2) 5'-flanking region: identification of a 268-bp region as the basal BACE2 promoter
Bryan Maloney, Yuan-Wen Ge, Nigel H Greig, et al.
CNS & Neurological Disorders Drug Targets
|
October 28, 2014
Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus
Gohar Mushtaq, Nigel H Greig, Jalaluddin A Khan, et al.
Neuroscience and Biobehavioral Reviews
|
March 15, 2023
Current update on management strategies for neurological and psychological disorders
Rupesh K Gautam, Aziz Unnisa, Nigel H Greig, et al.
Pharmacological Research
|
November 13, 2022
Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment
Katherine O Kopp, Elliot J Glotfelty, Yazhou Li, et al.
Neuroscience Letters
|
December 2, 2009
Memantine treatment decreases levels of secreted Alzheimer's amyloid precursor protein (APP) and amyloid beta (A beta) peptide in the human neuroblastoma cells
Balmiki Ray, Pradeep K Banerjee, Nigel H Greig, et al.
International Journal of Alzheimer'S Disease
|
September 28, 2010
Neuroinflammation, AD, and Dementia
Marcella Reale, Talma Brenner, Nigel H Greig, et al.
Annals of Neurology
|
August 23, 2014
Amyloid-β precursor protein synthesis inhibitors for Alzheimer's disease treatment
Nigel H Greig, Kumar Sambamurti, Debomoy K Lahiri, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
February 18, 2014
Lessons from a BACE1 inhibitor trial: off-site but not off base
Debomoy K Lahiri, Bryan Maloney, Justin M Long, et al.
Frontiers in Cell and Developmental Biology
|
December 24, 2019
Neuroinflammation as a Factor of Neurodegenerative Disease: Thalidomide Analogs as Treatments
Yoo Jin Jung, David Tweedie, Michael T Scerba, et al.
Neurobiology of Aging
|
December 11, 2007
Presenilin-1 mutation impairs cholinergic modulation of synaptic plasticity and suppresses NMDA currents in hippocampus slices
Yue Wang, Nigel H Greig, Qian-sheng Yu, et al.
Page
of 34